Shandong Boyuan Pharmaceutical&Chemical
301617
FORSTAR
835640
Cre8 Direct(Ningbo)Co.,Ltd.
300703
Minami Acoustics
301383
ASR Microelectronics
688220
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Goods sale service render cash | 15.80%15.95B | 10.37%10.29B | 29.88%5.35B | 16.99%19.54B | 8.87%13.78B | 10.49%9.33B | 17.75%4.12B | 30.41%16.7B | 13.64%12.65B | 18.47%8.44B |
Refunds of taxes and levies | -1.66%112.85M | 8.47%97.96M | -44.13%21.84M | 9.10%198.09M | -37.22%114.75M | -7.02%90.31M | -44.53%39.1M | 54.10%181.56M | 83.88%182.79M | 71.39%97.13M |
Cash received relating to other operating activities | -11.77%132.9M | 61.19%97.2M | 171.01%74.61M | -8.60%153.76M | 44.25%150.62M | -18.46%60.3M | -17.39%27.53M | 27.07%168.23M | 34.97%104.42M | 54.54%73.95M |
Cash inflows from operating activities | 15.36%16.2B | 10.67%10.49B | 30.12%5.45B | 16.65%19.89B | 8.50%14.04B | 10.04%9.48B | 16.20%4.19B | 30.59%17.05B | 14.41%12.94B | 19.12%8.61B |
Goods services cash paid | 14.31%11.82B | 6.50%8.25B | 23.65%4.4B | 10.93%15.23B | -6.10%10.34B | 6.46%7.75B | 2.45%3.56B | 35.89%13.73B | 17.18%11.01B | 18.25%7.28B |
Staff behalf paid | 2.91%1.89B | 2.62%1.27B | 11.17%659.37M | 14.87%2.29B | 12.94%1.83B | 15.48%1.24B | 7.00%593.11M | 14.30%1.99B | 8.72%1.62B | 6.16%1.07B |
All taxes paid | -11.53%355.66M | -4.25%239.36M | -34.35%93.63M | 69.45%487.38M | 23.44%402.03M | 3.60%249.99M | 40.30%142.63M | 32.54%287.63M | 15.91%325.68M | 20.20%241.31M |
Cash paid relating to other operating activities | -34.22%371.42M | -57.01%173.51M | 6.85%279.29M | 52.84%812.96M | 112.53%564.66M | 108.37%403.56M | 65.53%261.38M | -7.90%531.91M | 0.16%265.69M | 5.77%193.67M |
Cash outflows from operating activities | 9.84%14.44B | 3.06%9.93B | 19.25%5.43B | 13.77%18.82B | -0.65%13.14B | 9.73%9.64B | 6.26%4.55B | 30.85%16.54B | 15.65%13.23B | 16.39%8.78B |
Adjustment items of net operating cash flow | --0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net cash flows from operating activities | 96.03%1.76B | 443.81%554.93M | 105.47%19.98M | 110.07%1.07B | 412.82%898.7M | 6.05%-161.41M | 46.38%-365.17M | 22.68%510.3M | -126.30%-287.29M | 45.86%-171.8M |
Investing cash flow | ||||||||||
Cash received from disposal of investments | --1.17B | --99.99M | ---- | ---- | ---- | ---- | -99.09%1.88M | 0.00%100M | 143.20%243.53M | 147.86%247.86M |
Cash received from returns on investments | 526.94%12.21M | --340K | ---- | -55.64%2.93M | -52.75%1.95M | ---- | 134.37%442.18K | 140.52%6.61M | 58.17%4.12M | 2.52%2.09M |
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 8.69%33.24M | 123.77%32.58M | -7.27%1.47M | 81.66%154.78M | -49.00%30.59M | -66.90%14.56M | -96.24%1.59M | -44.56%85.21M | -59.48%59.97M | -48.24%44M |
Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | -33.33%29.27M | --29.27M | --29.27M | --29.27M | --43.91M | ---- | ---- |
Cash received relating to other investing activities | --76.25M | --76.29M | --43.05M | --190.32M | ---- | ---- | ---- | ---- | ---- | ---- |
Cash inflows from investing activities | 1,995.65%1.3B | 377.25%209.21M | 34.17%44.52M | 60.06%377.3M | -79.91%61.81M | -85.09%43.84M | -86.68%33.18M | -8.08%235.73M | 22.69%307.63M | 57.16%293.95M |
Cash paid to acquire fixed assets intangible assets and other long-term assets | 27.24%575.96M | 61.93%431.06M | 38.97%259.75M | 21.76%874.11M | 1.43%452.66M | -12.14%266.2M | 10.28%186.91M | 16.62%717.88M | -6.92%446.27M | 1.13%302.98M |
Cash paid to acquire investments | --1.64B | --280M | 964.92%20M | --234.07M | ---- | ---- | -97.37%1.88M | ---- | -42.89%509.01M | 4.04%104.04M |
Cash paid relating to other investing activities | --34.76M | --14.21M | --1.15K | --23.01M | ---- | ---- | ---- | ---- | ---- | ---- |
Cash outflows from investing activities | 398.02%2.25B | 172.46%725.27M | 48.18%279.76M | 57.57%1.13B | -52.62%452.66M | -34.60%266.2M | -21.64%188.79M | -56.02%717.88M | -30.31%955.29M | -63.90%407.02M |
Net cash flows from investing activities | -145.37%-959.02M | -132.08%-516.06M | -51.17%-235.23M | -56.36%-753.89M | 39.65%-390.85M | -96.66%-222.36M | -2,004.50%-155.61M | 64.95%-482.16M | 42.18%-647.65M | 87.98%-113.07M |
Financing cash flow | ||||||||||
Cash received from capital contributions | -27.57%35.49M | --35.52M | ---- | --224.88M | --49M | ---- | ---- | ---- | ---- | ---- |
-Including: Cash received from capital contributions by minority shareholders of subsidiaries | --35.49M | --35.52M | ---- | --224.88M | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from borrowing | -10.66%1.52B | -34.05%1.01B | -75.88%336.53M | -44.42%1.98B | -45.50%1.7B | -5.85%1.54B | 169.43%1.4B | 23.42%3.57B | -10.13%3.12B | -49.16%1.63B |
Cash received relating to other financing activities | -76.59%3.4M | ---- | ---- | --19.39M | --14.53M | --9.56M | --9.56M | ---- | ---- | ---- |
Cash inflows from financing activities | -11.67%1.56B | -32.16%1.05B | -76.04%336.53M | -37.58%2.23B | -43.47%1.77B | -5.27%1.54B | 171.28%1.4B | -34.65%3.57B | -38.20%3.12B | -49.16%1.63B |
Borrowing repayment | -8.46%1.48B | -24.74%1.03B | -67.54%460.52M | -41.67%2.24B | -55.96%1.61B | -3.07%1.37B | 86.23%1.42B | 42.15%3.84B | 46.60%3.66B | -40.19%1.41B |
Dividend interest payment | -16.27%145.44M | -37.39%64.77M | -28.88%26.78M | -28.89%206.6M | -36.84%173.69M | 76.87%103.46M | 119.49%37.65M | -5.14%290.53M | -0.35%274.99M | -75.07%58.49M |
-Including:Cash payments for dividends or profit to minority shareholders | -42.48%17.03M | -35.44%19.12M | ---- | 51.01%35.84M | 55.11%29.62M | 55.11%29.62M | ---- | -47.84%23.73M | -52.89%19.09M | -52.89%19.09M |
Cash payments relating to other financing activities | 39.55%41.44M | 319.15%16.82M | 119.13%5.13M | -36.64%75.8M | 55.89%29.69M | -28.31%4.01M | 7.22%2.34M | 16.43%119.64M | 184.20%19.05M | --5.6M |
Cash outflows from financing activities | -8.42%1.66B | -24.70%1.11B | -66.24%492.43M | -40.65%2.52B | -54.10%1.82B | 0.00%1.48B | 86.74%1.46B | 36.64%4.25B | 42.27%3.96B | -43.12%1.48B |
Net cash flows from financing activities | -105.14%-103.66M | -197.64%-65.06M | -189.48%-155.9M | 56.88%-291.26M | 93.94%-50.53M | -56.33%66.63M | 79.54%-53.85M | -128.67%-675.47M | -136.65%-833.18M | -74.93%152.56M |
Net cash flow | ||||||||||
Exchange rate change effecting cash and cash equivalents | -494.61%-27.23M | -25.98%-24.61M | 96.19%-1.67M | -101.28%-913.71K | -110.25%-4.58M | -218.79%-19.53M | -192.52%-43.74M | 659.42%71.53M | 525.31%44.68M | 591.74%16.44M |
Net increase in cash and cash equivalents | 48.39%671.82M | 84.91%-50.79M | 39.71%-372.82M | 104.51%25.94M | 126.27%452.75M | -190.59%-336.67M | 34.98%-618.37M | -141.61%-575.8M | -266.74%-1.72B | 82.25%-115.86M |
Add:Begin period cash and cash equivalents | 0.86%3.04B | 0.86%3.04B | 0.86%3.04B | -16.04%3.01B | -16.04%3.01B | -16.04%3.01B | -16.04%3.01B | 62.75%3.59B | 62.75%3.59B | 62.75%3.59B |
End period cash equivalent | 7.07%3.71B | 11.65%2.99B | 11.34%2.67B | 0.86%3.04B | 85.80%3.47B | -22.94%2.68B | -9.22%2.39B | -16.04%3.01B | -42.40%1.87B | 123.71%3.47B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
Auditor | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.